BIO-insync: BIO-integrated implantable systems for cell-based sensing and therapy
Active Other Transaction Agreement Awarded Last action
- Contract number
- 140D042490005
- Awardee
-
Carnegie-Mellon University UEI U3NKNFLNQ613
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $29,730,686
Award facts
- Contract value 71% obligated
-
- $29,730,686.00 Current, with exercised options
- $41,977,673.00 Potential, with all options
- Completion date 35% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Pittsburgh, PA 15213, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $29,730,686 |
About this award
The National Institutes of Health awarded an Other Transaction Agreement to Carnegie-Mellon University for BIO-INSYNC (Bio-Integrated Implantable Systems for Cell-Based Sensing and Therapy) on September 17, 2024, with a ceiling value of $41,977,673 and an ultimate completion date of September 16, 2030. This OTA sits outside the FAR and operates under alternative acquisition authority.
Work is performed in Pittsburgh, Pennsylvania. Carnegie-Mellon University leads the effort with subcontractors including the University of Pittsburgh (subawards issued October 29, 2025, and December 1, 2025), the University of Florida's Office of Engineering Research (subaward issued October 20, 2025), and Ginkgo Bioworks, Inc. (subaward issued September 17, 2024, for cell engineering, optimization, and production scaling to support standardized procedures for discovering, selecting, screening, engineering, and optimizing GMP-grade induced pluripotent stem cells for suitability in microenvironments within implantable device prototypes designed to correct metabolic dysfunction in patients with thyroid disorders).
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $286,877 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $193,242 | |
| University Of Florida | $357,824 | |
| Ginkgo Bioworks, Inc. | $3,819,525 |
Quick answers
Who was awarded contract 140D042490005?
140D042490005 was awarded to Carnegie-Mellon University by Interior Business Center (Office of Policy Management and Budget) on September 17, 2024.
How much is contract 140D042490005 worth?
The government has obligated $29,730,686 on 140D042490005. Its potential value, with all options, is $41,977,673.
Which agency awarded contract 140D042490005?
Interior Business Center (Office of Policy Management and Budget) awarded 140D042490005, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D042490005 competed?
The extent of competition for 140D042490005 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award